US5177097AExpiredUtility
Acyl amidine and acyl, guanidine substituted biphenyl derivatives
Est. expiryJul 24, 2011(expired)· nominal 20-yr term from priority
Inventors:Michael A. Poss
C07D 233/70C07C 271/66C07D 233/88C07C 279/24
92
PatentIndex Score
54
Cited by
12
References
8
Claims
Abstract
Novel compounds are disclosed having the formula ##STR1## and wherein R 1 , R 2 and R 3 are as defined herein. These compounds inhibit the action of angiotensin II and are useful, therefore, for example, as antihypertensive agents.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A compound of the formula ##STR20## pharmaceutically acceptable salts thereof; where R 1 is hydrogen, --COOH, --NHSO 2 CF 3 , ##STR21## R 2 is H, alkyl of 1 to 10 carbon atoms, alkenyl of 3 to 10 carbon atoms, or the same groups substituted with F; phenylalkenyl wherein the aliphatic portion is 2 to 6 carbon atoms; --(CH 2 ) m -imidazol-1-yl; --(CH 2 ) m -1,2,3-triazolyl optionally substituted with one or two groups selected from CO 2 R 7 or alkyl of 1 to 4 carbon atoms; --(CH 2 ) m -tetrazolyl; --(CH 2 ) n OR 6 ; ##STR22## R 3 is alkyl of 2 to 10 carbon atoms, alkenyl or alkynyl of 3 to 10 carbon atoms or the same groups substituted with F or CO 2 R 7 ; cycloalkyl of 3 to 8 carbon atoms, cycloalkylalkyl of 4 to 10 carbon atoms; cycloalkylalkenyl or cycloalkylalkynyl of 5 to 10 carbon atoms; --(CH 2 ) s Z(CH 2 ) m R' (wherein R' is H, C 1-6 alkyl, C 3-6 cycloalkyl, C 2-4 alkenyl or C 2-4 alkynyl) optionally substituted with F or CO 2 R 7 ; benzyl or benzyl substituted on the phenyl ring with 1 or 2 halogens, alkoxy of 1 to 4 carbon atoms, alkyl of 1 to 4 carbon atoms or nitro; R 6 is H, alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, phenyl or benzyl; R 7 to H, alkyl or perfluoroalkyl of 1 to 8 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, phenyl or benzyl; R 8 is H, alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, phenyl, benzyl, acyl of 1 to 4 carbon atoms, phenacyl; R 9 is H, alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, (CH 2 ) p C 6 H 5 , OR 11 or NR 12 R 13 ; R 10 is alkyl of 1 to 6 carbon atoms or perfluoroalkyl of 1 to 6 carbon atoms, 1-adamantyl, 1-naphthyl, 1-(1-naphthyl)ethyl, or (CH 2 ) p C 6 H 5 ; R 11 is H, alkyl of 1 to 6 carbon atoms, cyclalkyl of 3 to 6 carbon atoms, phenyl or benzyl; R 12 and R 13 independently are H, alkyl of 1 to 4 carbon atoms, phenyl, benzyl, α-methylbenzyl, or taken together form a ring of the formula ##STR23## Q is NR 14 , O or CH 2 ; R 14 and R 15 are independently H, alkyl, aryl, aralkyl or cycloalkyl; R 16 is C 1-6 alkyl, --NR 17 R 18 or ##STR24## R 17 and R 18 are independently H, C 1-6 alkyl, benzyl or taken together are 3 to 6 carbon atoms forming a 4- to 7-membered ring with the nitrogen atom to which they are attached; R 19 is H, C 1-5 alkyl, phenyl; R 20 is --CN, --NO 2 or --CO 2 R 7 ; Y=O or S; Z=O, NR 6 or S; m is 1-5; n is 1-10; p is 0-3; s is 0-5; and t is 0 or 1.
2. The compound of formula I as recited in claim 1 wherein R 1 is independently COOH or tetrazole; R 2 is selected from methyl, ethyl, --CH 2 OH; and R 3 is selected from n-butyl, n-propyl, NH-n-propyl.
3. The compound of formula I as recited in claim 1 wherein A is ##STR25## and R 1 is COOH; R 2 is methyl; and R 3 is propylamino.
4. The compound of formula I as recited in claim 1 having the name 4'-[[4,5-Dihydro-5-methyl-4-oxo-2-(propylamino)-1H-imidazol-1-yl]methyl]-[1,1'-biphenyl]-2-carboxylic acid, trifluoroacetate (1:1) salt.
5. A pharmaceutical composition comprising a compound of formula I as recited in claim 1 and a pharmaceutically acceptable carrier.
6. A method of treating hypertension comprising administering to a mammalian specie in need thereof a therapeutically effective amount of a composition of claim 5.
7. A method for treating congestive heart failure comprising administering to a mammalian specie in need thereof a therapeutically effective amount of a composition of claim 5.
8. A method for preventing cardiac hypertrophy comprising administering to a mammalian specie in need thereof a therapeutically effective amount of a composition of claim 5.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.